{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:50:42Z","timestamp":1776779442056,"version":"3.51.2"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The effect of immune cells on autoimmune diseases (ADs) complicated by non-Hodgkin lymphoma (NHL) has been widely recognized, but a causal relationship between regulatory T cell (Treg) immune traits and ADs complicated by NHL remains debated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Aggregate data for 84 Treg-related immune traits were downloaded from the Genome-Wide Association Study (GWAS) catalog, and GWAS data for diffuse large B-cell lymphoma (DLBCL; n=315243), follicular lymphoma (FL; n=325831), sj\u00f6gren\u2019s syndrome (SS; n=402090), rheumatoid arthritis (RA; n=276465), dermatopolymyositis (DM; n=311640), psoriasis (n=407876), atopic dermatitis (AD; n=382254), ulcerative colitis (UC; n=411317), crohn\u2019s disease(CD; n=411973) and systemic lupus erythematosus (SLE; n=307587) were downloaded from the FinnGen database. The inverse variance weighting (IVW) method was mainly used to infer any causal association between Treg-related immune traits and DLBCL, FL, SS, DM, RA, Psoriasis, AD, UC, CD and SLE, supplemented by MR-Egger, weighted median, simple mode, and weighted mode. Moreover, we performed sensitivity analyses to assess the validity of the causal relationships.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There was a potential genetic predisposition association identified between CD39+ CD8br AC, CD39+ CD8br % T cell, and the risk of DLBCL (OR=1.51, p&amp;lt;0.001; OR=1.25, p=0.001) (adjusted FDR&amp;lt;0.1). Genetic prediction revealed potential associations between CD25++ CD8br AC, CD28- CD25++ CD8br % T cell, CD39+ CD8br % CD8br, and the risk of FL (OR=1.13, p=0.022; OR=1.28, p=0.042; OR=0.90, p=0.016) (adjusted FDR&amp;gt;0.1). Furthermore, SLE and CD exhibited a genetically predicted potential association with the CD39+ CD8+ Tregs subset. SS and DM were possibly associated with an increase in the quantity of the CD4+ Tregs subset; RA may have reduced the quantity of the CD39+ CD8+ Tregs subset, although no causal relationship was identified. Sensitivity analyses supported the robustness of our findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>There existed a genetically predicted potential association between the CD39+ CD8+ Tregs subset and the risk of DLBCL, while SLE and CD were genetically predicted to be potentially associated with the CD39+ CD8+ Tregs subset. The CD39+ CD8+ Tregs subset potentially aided in the clinical diagnosis and treatment of SLE or CD complicated by DLBCL.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1374938","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T05:13:10Z","timestamp":1716873190000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Exploring risk factors for autoimmune diseases complicated by non-hodgkin lymphoma through regulatory T cell immune-related traits: a Mendelian randomization study"],"prefix":"10.3389","volume":"15","author":[{"given":"Qi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xintong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chundi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2018.11.004","article-title":"Systemic lupus erythematosus and lymphoma: incidence, pathogenesis and biology","volume":"75","author":"Klein","year":"2018","journal-title":"Leuk Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coms.2013.09.002","article-title":"Sjogren\u2019s syndrome: an update on epidemiology and current insights on pathophysiology","volume":"26","author":"Reksten","year":"2014","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0b013e31824125e4","article-title":"Prognosis and outcome of non-hodgkin lymphoma in primary sjogren syndrome","volume":"91","author":"Voulgarelis","year":"2012","journal-title":"Med (Baltimore)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyac053","article-title":"No increased risk of mature B-cell non-hodgkin lymphoma after Q fever detected: results from a 16-year ecological analysis of the dutch population incorporating the 2007-2010 Q fever outbreak","volume":"51","author":"Weehuizen","year":"2022","journal-title":"Int J Epidemiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00222","article-title":"P2 receptors as therapeutic targets in the salivary gland: from physiology to dysfunction","volume":"11","author":"Khalafalla","year":"2020","journal-title":"Front Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/biom11010116","article-title":"Immune monitoring upon treatment with biologics in sjogren\u2019s syndrome: the what, where, when, and how","volume":"11","author":"van Beers","year":"2021","journal-title":"Biomolecules"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/cancers14061469","article-title":"Tumor immune microenvironment in lymphoma: focus on epigenetics","volume":"14","author":"Garcia-Dominguez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.4.2579","article-title":"Deficient cd4+Cd25high T regulatory cell function in patients with active systemic lupus erythematosus","volume":"178","author":"Valencia","year":"2007","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxn044","article-title":"Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (Sle)","volume":"20","author":"Bonelli","year":"2008","journal-title":"Int Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/art.38119","article-title":"The percentage of foxp3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosus","volume":"65","author":"Golding","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202216","article-title":"Foxp3+ Helios+ Regulatory T cells are expanded in active systemic lupus erythematosus","volume":"72","author":"Alexander","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.17925\/EE.2023.19.2.7","article-title":"Teplizumab in type 1 diabetes mellitus: an updated review","volume":"19","author":"Thakkar","year":"2023","journal-title":"touchREV Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-022-01208-3","article-title":"Proximity-enabled covalent binding of il-2 to il-2ralpha selectively activates regulatory T cells and suppresses autoimmunity","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/biomedicines11010173","article-title":"The immunosuppressive effect of tnfr2 expression in the colorectal cancer microenvironment","volume":"11","author":"Mohd Salim","year":"2023","journal-title":"Biomedicines"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.981371","article-title":"Natural killer cells-related immune traits and amyotrophic lateral sclerosis: A mendelian randomization study","volume":"16","author":"Gong","year":"2022","journal-title":"Front Neurosci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy","volume":"52","author":"Orru","year":"2020","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1339649","article-title":"Causal relationship between immune cells and neurodegenerative diseases: A two-sample mendelian randomisation study","volume":"15","author":"Tang","year":"2024","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","author":"Genomes Project","year":"2012","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Genomes Project","year":"2015","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1166860","article-title":"Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: current research and future perspective","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2021.12.006","article-title":"A pd1 targeted nano-delivery system based on epigenetic alterations of T cell responses in the treatment of gastric cancer","volume":"24","author":"Hu","year":"2022","journal-title":"Mol Ther Oncolytics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101824","article-title":"Fam198b as a novel biomarker for gastric cancer and a potential therapeutic target to prevent tumor cell proliferation dysregulation","volume":"39","author":"Chen","year":"2024","journal-title":"Transl Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.3390\/ijms23137080","article-title":"Risk factors from pregnancy to adulthood in multiple sclerosis outcome","volume":"23","author":"Gonzalez-Madrid","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/ph15091080","article-title":"Tackling inflammatory bowel diseases: targeting proinflammatory cytokines and lymphocyte homing","volume":"15","author":"Song","year":"2022","journal-title":"Pharm (Basel)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1278759","article-title":"Treg in inborn errors of immunity: gaps, knowns and future perspectives","volume":"14","author":"Kennedy-Batalla","year":"2023","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3109\/08916931003782171","article-title":"Cd8(+) T regulatory\/suppressor cells and their relationships with autoreactivity and autoimmunity","volume":"44","author":"Filaci","year":"2011","journal-title":"Autoimmunity"},{"key":"B30","first-page":"63","article-title":"Memory cd4(+) T cells are suppressed by cd8(+) regulatory T cells in vitro and in vivo","volume":"9","author":"Long","year":"2017","journal-title":"Am J Transl Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002258","article-title":"Advances on cd8+ Treg cells and their potential in transplantation","volume":"102","author":"Bezie","year":"2018","journal-title":"Transplantation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17935","article-title":"Regulatory functions of cd8+Cd28- T cells in an autoimmune disease model","volume":"112","author":"Najafian","year":"2003","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1525098113","article-title":"Cd8+Cd122+Cd49dlow regulatory T cells maintain T-cell homeostasis by killing activated T cells via fas\/fasl-mediated cytotoxicity","volume":"113","author":"Akane","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi9591","article-title":"Kir(+)Cd8(+) T cells suppress pathogenic T cells and are active in autoimmune diseases and covid-19","volume":"376","author":"Li","year":"2022","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081344","article-title":"Cd8(+) treg cells associated with decreasing disease activity after intravenous methylprednisolone pulse therapy in lupus nephritis with heavy proteinuria","volume":"9","author":"Tsai","year":"2014","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0513297","article-title":"Differential role of all-trans retinoic acid in promoting the development of cd4+ and cd8+ Regulatory T cells","volume":"95","author":"Ma","year":"2014","journal-title":"J Leukoc Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901773","article-title":"Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and tgf-beta-producing cd8+ Treg cells are associated with immunological remission of lupus","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242758","article-title":"Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of qa-1-restricted cd8(+) regulatory cells","volume":"43","author":"Yao","year":"2013","journal-title":"Eur J Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00563","article-title":"Evidence for il-35 expression in diffuse large B-cell lymphoma and impact on the patient\u2019s prognosis","volume":"9","author":"Larousserie","year":"2019","journal-title":"Front Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.7.2169.bloodjournal8272169","article-title":"Serum interleukin-10 in non-hodgkin\u2019s lymphoma: A prognostic factor","volume":"82","author":"Blay","year":"1993","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12032-021-01504-y","article-title":"The role of interleukins and the widely studied tnf-alpha in non-hodgkin\u2019s lymphoma","volume":"38","author":"D\u2019Mello","year":"2021","journal-title":"Med Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of il-10(+) and il-35(+) T(Reg) cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01371","article-title":"Myeloid-derived suppressor cells in tumors: from mechanisms to antigen specificity and microenvironmental regulation","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.047423","article-title":"Generation and accumulation of immunosuppressive adenosine by human cd4+Cd25highfoxp3+ Regulatory T cells","volume":"285","author":"Mandapathil","year":"2010","journal-title":"J Biol Chem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases cd39 and cd73: novel checkpoint inhibitor targets","volume":"276","author":"Allard","year":"2017","journal-title":"Immunol Rev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21533","article-title":"The importance of cd39, cd43, cd81, and cd95 expression for differentiating B cell lymphoma by flow cytometry","volume":"94","author":"Cardoso","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1392-z","article-title":"Cd39 is highly involved in mediating the suppression activity of tumor-infiltrating cd8+ T regulatory lymphocytes","volume":"62","author":"Parodi","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.07.014","article-title":"Cd8+Cd103+ Itregs inhibit chronic graft-versus-host disease with lupus nephritis by the increased expression of cd39","volume":"27","author":"Zhang","year":"2019","journal-title":"Mol Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40364-023-00500-w","article-title":"Review immune response of targeting cd39 in cancer","volume":"11","author":"Liu","year":"2023","journal-title":"biomark Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20806","article-title":"Fgl1-lag3 axis impairs il-10-producing regulatory T cells associated with systemic lupus erythematosus disease activity","volume":"9","author":"Chen","year":"2023","journal-title":"Heliyon"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5583994","article-title":"Regulatory effect of mesenchymal stem cells on T cell phenotypes in autoimmune diseases","volume":"2021","author":"Wei","year":"2021","journal-title":"Stem Cells Int"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2007.01882.x","article-title":"The quantitative analysis of peripheral blood foxp3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients","volume":"37","author":"Lin","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1186\/s12888-023-05081-4","article-title":"Causal role of immune cells in schizophrenia: mendelian randomization (Mr) study","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e1048","DOI":"10.1002\/iid3.1048","article-title":"Inflammatory bowel disease and the risk of intracerebral hemorrhage: A mendelian randomization study and meta-analysis","volume":"11","author":"Song","year":"2023","journal-title":"Immun Inflammation Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1256874","article-title":"The causality between gut microbiome and liver cirrhosis: A bi-directional two-sample mendelian randomization analysis","volume":"14","author":"Xiao","year":"2023","journal-title":"Front Microbiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.860794","article-title":"Association between systemic lupus erythematosus and cancer morbidity and mortality: findings from cohort studies","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.3390\/nu15184051","article-title":"Calcium homeostasis and psychiatric disorders: A mendelian randomization study","volume":"15","author":"Jiang","year":"2023","journal-title":"Nutrients"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1374938\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T05:13:12Z","timestamp":1716873192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1374938\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2024.1374938"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1374938","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"article-number":"1374938"}}